UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Mousa Shamonki, MD

Print
Email

Mousa Shamonki, MD

This physician is an affiliate of the UCLA Medical Group but is not employed by UCLA.
UCLA Physician Mousa Shamonki, MD specializes in Obstetrics, Reproductive Endocrinology.
Specialty
Obstetrics, Reproductive Endocrinology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
State License Number
A95374
Contact
(310) 794-7274 Appointments
(310) 825-9500 IVF
Fax Number
(310) 794-2168
Email Address
obgyn@mednet.ucla.edu
Voted Best Doctor
PRACTICE LOCATION

UCLA Department of Obstetrics & Gynecology
200 Medical Plaza, Suite 220
Los Angeles, CA 90095

MEDICAL BOARD CERTIFICATION
Reproductive Endocrinology, American Board of Obstetrics and Gynecology, 2008
Obstetrics & Gynecology, American Board of Obstetrics and Gynecology, 2005, 2014
EDUCATION
Fellowship
Reproductive Endocrinology & Infertility, Weill Cornell Medical College, 2002 - 2005
Residency
Obstetrics & Gynecology, University of Vermont/Fletcher Allen Health Care, 1999 - 2002
Internship
Obstetrics & Gynecology, University of Vermont/Fletcher Allen Health Care, 1998 - 1999
Degree
MD, University of Vermont College of Medicine, 1998
CLINICAL INTEREST
Endoscopic Surgery, Endoscopy, Fibroids, Gynecologic Ultrasound, Hirsutism & Masculinization, Hysteroscopy, In Vitro Fertilization, Infertility, Laparoscopy, Laser, Polycystic Ovarian Syndrome, Preconception Consults, Recurrent Pregnancy Loss, Reproductive Endocrinology, Robotic Surgery, Tubal Reversal
AFFILIATION
MORE INFORMATION
Additional Information

Dr. Shamonki received his medical degree and OB/GYN residency training at the University of Vermont. He completed his reproductive endocrinology and infertility fellowship at Cornell University, after which he joined Reproductive Medicine Associates of New Jersey for one year to refine his IVF-related techniques. In 2006 Dr. Shamonki joined UCLA and, as Director of In Vitro Fertilization and Assisted Reproduction, developed the UCLA IVF Program into a premier IVF Center. Dr. Shamonki has published numerous papers and has won several awards, including the Carbee Award for excellence in obstetrics and gynecology, the Patients' Choice Award and America's Top Doctors Award.

In his words- "I had the great fortune of growing up learning about reproductive medicine through the eyes of my father, Dr. Issa Shamonki, who was one of the pioneers in the field. Each day I would see him come home from work happy and fulfilled, having done his best for each and every patient while demonstrating warmth, kindness and attention to detail. I hope to continue his legacy by providing care of the highest quality, with great compassion and consideration."

PROFESSIONAL EXPERIENCE
  • 2007 - Present Director, In Vitro Fertilization and Assisted Reproduction, David Geffen School of Medicine at UCLA, Department of Obstetrics and Gynecology
  • 2006 - Present  Assistant Clinical Professor in Reproductive Endocrinology and Infertility, David Geffen School of Medicine at UCLA, Department of Obstetrics and Gynecology
  • 2005 - 2006  Attending in Reproductive Endocrinology and Infertility, Reproductive Medicine Associates of New Jersey
  • 2002 - 2005  Fellow in Reproductive Endocrinology and Infertility, The Center for Reproductive Medicine and Infertility
  • 1998 - 2002  Faculty Position as Clinical Instructor, University of Vermont College of Medicine/Fletcher Allen Health Care

POSTGRADUATE MEDICAL EDUCATION

  • 1998 - 2002  Resident in Obstetrics and Gynecology, completed June 2002, University of Vermont College of Medicine/Fletcher Allen Health Care

UNDERGRADUATE EDUCATION

  • 1989 - 1993  University of California, Los Angeles (UCLA), Bachelors in Science, Biology, June 1993

RESEARCH EXPERIENCE

  • 2005 Mouse oocytes reconstituted with somatic or germ cell nuclei, under Gianpiero Palermo, MD, and Takumi Takeuchi, MD, CRMI
  • 2003 - 2005 Examination of immunohistochemical expression of the L-selectin ligand on receptive human endometrium and its relationship to pregnancy outcome, under Isaac Kligman, MD, Steven Spandorfer, MD, and Zev Rosenwaks, MD, CRMI
  • 2004 - 2005 Prospective analysis on the benefit of ultrasound-guided trial transfer in preparation for an in vitro fertilization cycle, under Glenn Schattman, MD, CRMI
  • 2004 - 2005 Case-control analysis on the influence of male factor infertility on the progression of day-3 embryos to blastocyst, under Pak Chung, MD, CRMI
  • 2002 - 2003 Prospective analysis of ultrasound-guided embryo transfer and the accuracy of trial transfer, under Steven Spandorfer, MD, CRMI
  • 2002 - 2003 Retrospective analysis of the success of low-dose gonadotropin step-up protocol during ovulation induction for the PCOS patient, under Steven Spandorfer, MD, CRMI
  • 1998 - 2000 Comparison of laparoscopy with laparotomy for the treatment of endometrial cancer, under Gamal Eltabbakh, MD, Division of Gynecologic Oncology, UVM
  • 1997 Analysis of long-term outcome of endometrial ablation for menometrorrhagia, under Cynthia Sites, MD, Department of Obstetrics and Gynecology, UVM
  • 1993 - 1994 Investigation of the effects of alpha-bungarotoxin on brain and muscle acetylcholine receptors in the frog oocyte, under Ricardo Miledi, MD, PhD, Department of Neurobiology, University of California, Irvine (UCI)
  • 1992 Examination of a new cell ablation technique on the eye disc of Drosophila larvae in vivo, under Utpal Banerjee, PhD, Department of Genetics, UCLA
  • 1991 Exploration of the effects of adenosine on the in utero brain of fetal sheep via microdialysis, under Brian Koos, MD, PhD, Department of Obstetrics and Gynecology, UCLA
  • 1990 Vascular effects of chemicals and hormones in Rattus, performed catheterization of the rat carotid artery and femoral vein, under Gautum Chaudhuri, MD, PhD, Departments of Obstetrics and Gynecology and Pharmacology, UCLA


MEMBERSHIPS

  • 2006 - Present Fellow of the American College of Obstetricians and Gynecologists
  • 2005 - Present Diplomate of the American Board of Obstetrics and Gynocology
  • 2002 - Present American Society of Reproductive Medicine
  • 2002 - Present Society of Reproductive Endocrinology and Infertility
  • 2002 - 2006 American Academy of Gynecologic Laparoscopy
  • 1998 - 2006 Junior Fellow American College of Obstetricians and Gynecologists
  • 1994 - 1998 American Medical Student Association
  • 1994 - 1998 American College of Physicians
  • 1994 - 1998 American Academy of Family Physicians
Awards & Recognition
  • America's Top Doctor, 2011
  • Patient's Choice Award, 2008
  • Best resident research presentation, University of Vermont College of Medicine/Fletcher Allen Health Care, 2002
  • American Association of Gynecologic Laparoscopists Award, Best resident surgeon in minimally invasive surgery, University of Vermont College of Medicine/Fletcher Allen Health Care, 2002
  • Best resident teacher in obstetrics and gynecology, Vermont College of Medicine/Fletcher Allen Health Care, Fall 2000
  • Best resident teacher in obstetrics and gynecology, Vermont College of Medicine/Fletcher Allen Health Care, Summer 2000
  • Best resident teacher in obstetrics and gynecology, Vermont College of Medicine/Fletcher Allen Health Care, Winter 2000
  • Best resident teacher in obstetrics and gynecology, Vermont College of Medicine/Fletcher Allen Health Care, Winter 1999
    Carvee Award for excellence in obstetrics and gynecology, University of Vermont College of Medicine, 1998
  • Phi Beta Kappa awarded as a medical student, University of Vermont College of Medicine, 1998
  • Alpha Omega Alpha as a 3rd year medical student, University of Vermont College of Medicine, 1997
  • Dean's List, University of California, Los Angeles, 1993
Publications
  1. Shamonki MI, Squatrito RC, Welander CE.  Advanced ovarian carcinoma presenting with a cerebrovascular accident.  Gynecol Oncol 1998;70(2):300-2.
  2. Shamonki MI, Ziegler WF, Badger GJ, Sites CK.  Prediction of endometrial ablation success according to perioperative findings.  Am J Obstet Gynecol 2000;182(5):1005-7.
  3. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL.  Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?  Gynecol Oncol 2000;78(3):329-35. 
  4. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL.  Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma.  Cancer 2001;91(2):378-87.
  5. Shamonki MI, Spandorfer SD, Rosenwaks Z.  Ultrasound-guided embryo transfer and accuracy of trial transfer. Hum Reprod 2005;20(3):709-716.
  6. Shamonki MI, Oktay K. Oocyte and ovarian cryopreservation: indications, techniques, and applications. Semin Reprod Bio 2005;23:266-76.
  7. Sonmezer M, Shamonki MI, Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005;322:125-32.
  8. Shamonki MI, Schattman GL, Spandorfer SD, Chung PH, Rosenwaks Z. Ultrasound-guided trial transfer can be beneficial in preparation for an in-vitro fertilization cycle. Hum Reprod 2005;20:2844-9.
  9. Shamonki MI, Kligman I, Shamonki JM, Schattman GL, Hyjek E, Spandorfer SD, Rosenwaks Z. Immunohistochemical expression of endometrial L-selectin ligand is higher in donor egg-recipients with embryonic implantation. Fertil Steril 2006;86:1365-1375.
  10. Glujovsky D, Shamonki MI, Bergh PA. Embryonic synergism may reduce pregnancy loss: a multivariate regression analysis. Fertil Steril 2007;87:509-14.
  11. Shamonki MI, Frattarelli JL, Bergh PA, Scott RT. Logarithmic curves depicting  initial level and rise of serum beta human chorionic gonadotropin and live  delivery outcomes with in vitro fertilization: An analysis of 6021 pregnancies. Fertil Steril 2009;91:1760-4.

Abstracts and Presentations

  1. Ziegler W, Shamonki MI, Badger G, Sites CK.  Factors predicting the success or failure of endometrial ablation. American College of Obstetricians and Gynecology Annual Meeting, May 1998.
  2. Shamonki MI, Ziegler WF, Badger GJ, Sites CK.  Prediction of endometrial ablation success according to perioperative findings.  American College of Obstetricians and Gynecology District I Conference, Burlington, VT, September 1999.
  3. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL.  Laparoscopy as the primary modality for management of women with endometrial cancer.  Gynecologic Oncology 2000; 76: 233-4 (Abstract #14).
  4. Shamonki MI, Spandorfer SD, Roberts JE, Rosenwaks Z.  Ultrasound-guided embryo transfer: Does it improve IVF success?  Fertil Steril 2003; 80(3):127-8.  ASRM in San Antonio, TX, Oct. 2003.
  5. Shamonki MI, Spandorfer SD, Fasouliotis SJ, Rosenwaks Z.  Low-dose gonadotropin step-up protocol is highly successful for the PCOS patient.  Fertil Steril 2003; 80(3):171.  ASRM in San Antonio, TX, Oct. 2003.
  6. Roberts JE, Spandorfer SD, Fasouliotis SJ, Shamonki MI, Rosenwaks Z.  Follicle Stimulating Hormone (FSH) secreting pituitary adenoma causing spontaneous ovarian hyperstimulation syndrome.  Fertil Steril 2003; 80(3):271-2.  ASRM in San Antonio, TX, Oct. 2003.
  7. Shamonki MI, Rosenwaks Z.  Prevention of ovarian hyperstimulation syndrome.  Syllabus for postgraduate course at ASRM in San Antonio, TX, Oct. 2003.
  8. Fasouliotis SJ, Galindo A, Kashyap S, Spandorfer SD, Shamonki MI, Rosenwaks Z, Schattman GL. Prospective analysis of the predictive value of day 3 antral follicle count and ovarian volume In-Vitro Fertilization (IVF) cycles. ESHRE Madrid June 2004.
  9. Shamonki MI, Kligman I, Schattman GL, Shamonki JM, Zaninovic N, Rosenwaks Z.  Presence of the L-selectin ligand by immunohistochemistry is significantly lower on the endometrium obtained from donor egg-recipients who fail to conceive. ASRM in Philadelphia, PA, Oct. 2004.
  10. Shamonki MI, Kligman I, Spandorfer SD, Shamonki JM, Zaninovic N, Rosenwaks Z.  Immunohistochemical staining characteristics of the L-selectin ligand in hormonally programmed and natural cycle luteal endometrium. ASRM in Philadelphia, PA, Oct. 2004.
  11. Shamonki MI, Thompson S, Chung PH, Spandorfer SD, Veeck LL, Rosenwaks Z.  The influence of male factor infertility on the progression of day-3 embryos to blastocyst: a case-control study. ASRM in Philadelphia, PA, Oct. 2004.
  12. Shamonki MI, Spandorfer SD, Chung PH, Rosenwaks Z Schattman GL.  Ultrasound-guided sounding may be of benefit in preparation for an in-vitro fertilization cycle. ASRM in Philadelphia, PA, Oct. 2004.
  13. Zaninovic N, Shamonki MI, Park J, Spandorfer SD, Veeck LL, Rosenwaks Z.  Detection of L-selectin and its ligand on human endometrial cell cultures in vitro. ASRM in Philadelphia, PA, Oct. 2004.
  14. Spandorfer SD, Fasouliotis SJ, Shamonki MI, Park J, Witkin SS, Rosenwaks Z. Autologous Endometrial Co-Culture (AECC) in patients with IVF failure: Correlations of adhesion molecules and outcome. ASRM in Philadelphia, PA, Oct. 2004.
  15. Jakus S, Shamonki MI, Spandorfer SD, Rosenwaks Z. Natural Cycle and Timing of Intrauterine Insemination: HCG vs Spontaneous LH surge. ASRM in Montreal, Quebec, Canada, Oct. 2005.
  16. Shamonki MI, Kligman I, Shamonki JM, Zaninovic N, Rosenwaks Z, Spandorfer SD. Immunohistochemical expression of endometrial L-selectin ligand obtained during the natural menstrual cycle from women undergoing autologous endometrial coculture. ASRM in Montreal, Quebec, Canada, Oct. 2005.
  17. Shamonki MI, Kligman I, Spandorfer SD, Shamonki JM, Zaninovic N, Rosenwaks Z. Comparison of L-selectin ligand expression by immunohistochemistry in human luteal endometrium obtained from natural and hormone replacement cycles. ASRM in Montreal, Quebec, Canada, Oct. 2005.
  18. Scott R, Styne A, Shamonki M, Miller K. The predictive value of ovarian reserve screening with basal follicle stimulating hormone (FSH) levels is greatly impacted by the method used to select the threshold between normal and elevated basal FSH values. ASRM in New Orleans, LA, Oct. 2006.
  19. Shamonki MI, Glujovsky D, Wambach CM, Miller KA, Bergh PA. Formula predicting progression to blastocyst using characteristics from the first three days of development of 34,708 embryos. ASRM in Washington, DC, Oct. 2007.
  20. Agard J, Glujovsky D, Shamonki MI, Frattarelli J, Bergh PA. Estradiol levels after human chorionic gonadotropin (hCG) administration are not predicitive of IVF outcome: analysis of 7,474 initial fresh IVF cycles. ASRM in Washington, DC, Oct. 2007.
  21. Wambach CM, Gueye A, Shamonki MI, Glujovsky D, Miller KA, Bergh PA. The number of blastomeres on day-2 and the progression to blastocyst: an analysis of 34,883 embryos.  ASRM in Washington, DC, Oct. 2007.
  22. Wambach CM, Shamonki MI, Glujovsky D, Miller KA, Bergh PA. Day-3 embryo morphology and progression to blastocyst: an analysis of 34,708 embryos. ASRM in Washington, DC, Oct. 2007.
Link to my PubMed publications.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Mousa Shamonki, click here to update your profile.